Drug intelligence / Profile preview

Phytofare

Development stage: Preclinical
Lead developer: Plandaí Biotechnology
Modality: Drug Delivery Systems, Small Molecules
Administration: Oral

Overview

Phytofare is a cannabis extract developed by Plandaí Biotechnology for medical and pharmaceutical applications. It is produced using proprietary hydrodynamic sheering and Pheroid™ technologies, which are designed to increase its bioavailability. A Pheroid™-enhanced version of Phytofare aims to potentially eliminate psychoactive effects, making it suitable for patients with neural disorders. It is intended to be marketed in capsule and oil forms.

Brand names: Diego Pellicer Gold

Beyond the preview

Go deeper on Phytofare.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phytofare.

Explore the full profile